Anticoccidial Drugs Market Elevates Poultry Wellness Globally

According to latest research report published by Market Data Forecast, the global anticoccidial drugs market will be worth USD 1468 million in 2024 and USD 1752 million by 2029, growing at a CAGR of 3.61 % from 2024 to 2029.

Anticoccidial drugs are used to prevent and control coccidia infections, commonly observed in animals. Coccidiosis is a gastrointestinal illness caused by protozoans. The symptoms include diarrhea, weight loss, lethargy, vomiting, signs of abdominal pain, and anorexia in the animals. Eimeria is a genus of apicomplexan parasites that includes various species causing coccidiosis in animals.

Global Anticoccidial Drugs Market Report Scope:
• Market Size (2029): USD 1752 Million
• Market Size (2024): USD 1468 Million
• CAGR (2024 to 2029): 3.61%
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: Drug Type, Animal Type, and Geography
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa
• Key Market Players Profiled Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.

Avail sample market brochure of the report, ask @ https://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market/request-sample

The growing prevalence of coccidiosis in a wide variety of animals across the globe is majorly contributing to the adoption of anticoccidial drugs. The coccidia is responsible for the livestock industry's significant economic losses, which is demanding for the anticoccidial drugs. According to a research article in August 2022, nearly 20 or more Eimeria species are identified in cattle feces worldwide. Another article stated that clinical infection usually starts at 1-2 months of age, as coccidiosis rarely manifests in the first three weeks of life-the increasing adoption of pet animals, which includes dogs, cats, and horses. The increasing practices of farming include farm animals like cattle and swine for commercial reasons. The increasing animal count in the world is increasing the prevalence of coccidiosis, which is demanding anticoccidial drugs for treatment by enhancing the global market revenue. The increasing concern of pet owners regarding the safety of their pets is creating demand for preventive and effective therapeutic products, which is boosting the global market share.
The growing research activities are due to the support of the government by funding research and creating awareness programs for the people regarding the diseases in animals. This helps in early diagnosis and preventive measures to control the disease by increasing the demand for anticoccidial drugs. The increasing number of veterinary hospitals and the care for animals worldwide, with rising healthcare expenditure and the increasing demand for the quality of the drugs, are enhancing the global market value. The increasing technological advancements escalating the research activities in developing effective drugs with minimal adverse reactions is augmenting the anticoccidial drugs market value.
The major restraining factor is the availability of alternative methods for treating coccidiosis, which include other antibiotic drugs or traditional methods, which may hamper the adoption of anticoccidial drugs, impacting the market revenue. The increasing demand for medicine-free meat among the people is expected to limit the global market expansion. The presence of specific stringent regulations and guidelines that may restrict the usage of anticoccidial drugs in livestock will restrain the growth of the global anticoccidial drugs market. The side effects of the drugs, including low feed intake and higher cost, are estimated to impede the animal adoption rate.

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market

Key Insights from The Report:
• By drug type, the ionophore anticoccidials segment witnessed the highest global market share in 2023.
• Based on drug type, the antibiotic anticoccidials drug segment is expected to grow at the fastest CAGR during the forecast period.
• Based on animal type, the poultry animal segment led the anticoccidial drugs market in 2023, and the segment's domination is likely to continue during the forecast period.
• North America dominated the anticoccidial market in 2023. Europe accounted for second-highest share of the global market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, are dominated the anticoccidial market.

The report can be customized as per the requirements, ask @ https://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market/customization

SEGMENTATION INCLUDED IN THIS REPORT:
By Drug Type:
• Antibiotic Anticoccidials
• Ionophore Anticoccidials
• Chemical Derivative Anticoccidials
By Animal Type:
• Poultry
• Swine
• Fish
• Cattle
• Companion Animal
By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Browse Regional Reports:
North America Anticoccidial Drugs Market Research Report - Segmented By Drug Type , Animal Type , & Country (U.S, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/north-america-anticoccidial-drugs-market
Europe Anticoccidial Drugs Market Research Report - Segmented By Drug Type, Animals & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/europe-anticoccidial-drugs-market
APAC Anticoccidial Drugs Market Research Report - Segmented By Drug Type, Animals & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/asia-pacific-anticoccidial-drugs-market
Latin America Anticoccidial Drugs Market Research Report - Segmented By Drug Type, Animals & By Country (Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/latin-america-anticoccidial-drugs-market
Middle East & Africa Anticoccidial Drugs Market Research Report - Segmented By Drug Type, Animals & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan and Rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast from (2024 to 2029) - https://www.marketdataforecast.com/market-reports/middle-east-and-africa-anticoccidial-drugs-market

TABLE OF CONTENTS:
1. Introduction
1.1. Market Definition
1.2. Study Deliverables
1.3. Base Currency, Base Year and Forecast Periods
1.4. General Study Assumptions
2. Research Methodology
2.1. Introduction
2.2. Research Phases
2.2.1.1. Secondary Research
2.2.1.2. Primary Research
2.2.1.3. Econometric Modelling
2.2.1.4. Expert Validation
2.3. Analysis Design
2.4. Study Timeline
3. Overview
3.1. Executive Summary
3.2. Key Inferences
3.3. New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1. Market Drivers
4.2. Market Restraints
4.3. Key Challenges
4.4. Current Opportunities in the Market
5. Market Segmentation
5.1. By Drug Type
5.1.1. Antibiotic anticoccidials
5.1.2. Ionophore anticoccidials
5.1.3. Chemical derivative anticoccidials
5.1.4. Y-o-Y Growth Analysis, By Drug Type
5.1.5. Market Attractiveness Analysis, By Drug Type
5.1.6. Market Share Analysis, By Drug Type
5.2. By Animal Type
5.2.1. Poultry
5.2.2. Fish
5.2.3. Swine
5.2.4. Cattle
5.2.5. Companion Animal
5.2.6. Y-o-Y Growth Analysis, By Animal Type
5.2.7. Market Attractiveness Analysis, By Animal Type
5.2.8. Market Share Analysis, By Animal Type
6. Geographical Analysis
6.1. North America
6.1.1. Introduction
6.1.2. US
6.1.3. Canada
6.1.4. Mexico
6.1.5. Rest of North America
6.2. Europe
6.2.1. Introduction
6.2.2. UK
6.2.3. France
6.2.4. Spain
6.2.5. Germany
6.2.6. Italy
6.2.7. Russia
6.2.8. Sweden
6.2.9. Denmark
6.2.10. Switzerland
6.2.11. Netherlands
6.2.12. Turkey
6.2.13. Czech Republic
6.2.14. Rest of Europe
6.3. Asia-Pacific
6.3.1. Introduction
6.3.2. India
6.3.3. China
6.3.4. Japan
6.3.5. South Korea
6.3.6. Australia
6.3.7. New Zealand
6.3.8. Thailand
6.3.9. Malaysia
6.3.10. Vietnam
6.3.11. Philippines
6.3.12. Indonesia
6.3.13. Singapore
6.3.14. Rest of APAC
6.4. Latin America
6.4.1. Introduction
6.4.2. Brazil
6.4.3. Argentina
6.4.4. Chile
6.4.5. Rest of Latin America
6.5. Middle East & Africa
6.5.1. Introduction
6.5.2. KSA
6.5.3. UAE
6.5.4. Israel
6.5.5. Rest of GCC countries
6.5.6. South Africa
6.5.7. Ethiopia
6.5.8. Kenya
6.5.9. Egypt
6.5.10. Sudan
6.5.11. Rest of MEA
7. Strategic Analysis
7.1. PESTLE analysis
7.1.1. Political
7.1.2. Economic
7.1.3. Social
7.1.4. Technological
7.1.5. Legal
7.1.6. Environmental
7.2. Porter's Five analysis
7.2.1. Bargaining Power of Suppliers
7.2.2. Bargaining Power of Consumers
7.2.3. Threat of New Entrants
7.2.4. Threat of Substitute Products and Services
7.2.5. Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1. Bayer Health care
8.1.1. Overview
8.1.2. Product Analysis
8.1.3. Strategic Evaluation and Operations
8.1.4. Financial analysis
8.1.5. Legal issues
8.1.6. Recent Developments
8.1.7. SWOT analysis
8.1.8. Analyst View
8.2. Zoetis
8.3. Elanco
8.4. Merck Animal Healthcare
8.5. Virbac
8.6. Ceva Sante Animale
8.7. Boehringer Ingelheim Animal Healthcare
8.8. Novartis Animal Healthcare
8.9. Smartvet Inc.
9. Competitive Landscape
9.1. Market share analysis
9.2. Merger and Acquisition Analysis
9.3. Agreements, collaborations, and Joint Ventures
9.4. New Product Launches
10. Market Outlook and Investment Opportunities
11. Appendix
11.1. List of Tables
11.2. List of Figures

Contact Us:
MarketDataForecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.